循環器内科学
論文
A 欧文
A-a
1. Abe H, Takeda N, Isagawa T, Semba H, Nishimura S, Morioka MS, Nakagama Y, Sato T, Soma K, Koyama K, Wake M,Katoh M, Asagiri M, Neugent ML, Kim JW, Stockmann C, Yonezawa T, Inuzuka R, Hirota Y, Maemura K, Yamashita T, Otsu
K, Manabe I, Nagai R, Komuro I: Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. Nat Commun
10(1): 2824, 2019 (IF:11.878) ＊◇☆
2. Eto R, Kawano H, Horie I, Kaneko K, Honda T, Abe K, Koga S, Ikeda S, Maemura K: Paraganglioma of the Carotid Body andIntrapericardium. J Cardiol Cases 21(2): 63-66, 2019
3. Ikeda S, Koga S, Yamagata Y, Koide Y, Kawano H, Mukae H, Mamemura K. Pulmonary Thromboembolism Caused byCalcification in the Inferior Vena Cava of a Japanese Adult. Intern Med. 2019 ;58(13):1907-1912. (IF:0.956) ＊4. Izumida S, Kawano H, Muroya T, Motokawa T, Akashi R, Yonekura T, Morimoto Y, Yano Y, Ikeda S, Maemura K: The
Relationship between Circulating Polyunsaturated Fatty Acid Levels and Exercise Responses of Patients with Non-ischemic
Heart Failure. Intern Med 58(22): 3219-3225, 2019 (IF:0.956) ＊○5. Kajikawa M, Maruhashi T, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Yusoff FM, Kihara Y, Chayama K, Goto C,Noma K, Nakashima A, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K,Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H,Ikeda H, Yamashina A, Higashi Y: Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With
Coronary Artery Disease - Post Hoc Analysis of the FMD-J Study A. Circ J 83(5): 1064-1071, 2019 (IF:3.025) ＊6. Kawano H, Ando T, Shida Y, Niino D, Maemura K, Kawai K: Isolated Left Adrenal Medullary Hyperplasia. J Cardiol Cases
21(1): 16-19, 20197. Kawano H, Fujiwara A, Kai H, Kumagai E, Okamoto R, Shibata R, Ohtsubo T, Tamura K, Maemura K, Arima H: Effects ofblood pressure lowering in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Hypertens Res 42(4): 504-513, 2019 (IF:3.217) ＊8. Kawano H, Hayashi T, Koide Y, Maemura K: Long-Term Myocardial Damage in Peripartum Cardiomyopathy Associated With
Myocarditis. Circ J 83(12): 2569, 2019 (IF:3.025) ＊9. Kumagai A, Shimizu K, Kurata R, Cui X, Isagawa T, Harada M, Nagai J, Yoshida Y, Ozaki KI, Takeda N, Semba H,Yonezawa T: Establishment of Novel Cells Stably Secreting Various Human IL-18 Recombinant Proteins. Curr Pharm
Biotechnol 20(1): 47-55, 2019 (IF:1.516) ＊10. Kuwasaki S, Kawano H, Koga S, Abe K, Yonekura T, Ikeda S, Takenaka M, Maemura K: Calciphylaxis Diagnosed on Skin
Biopsy in a Patient With Left Posterior Tibial Artery Stenosis. Circ Rep. 1(7): 312, 2019
11. Kuwasaki S, Koga S, Akashi R, Ikeda S, Kawano H, Maemura K: Influence of Tyrosine Kinase Inhibitor, Nilotinib, on Delayed
Healing of Bare-Metal Stents in Superficial Femoral Arteries: Insights From Angioscopic Findings. JACC Cardiovasc Interv12(10): e85-e86, 2019 (IF:9.544) ＊12. Minami T, Kawano H, Tsuneto A, Maemura K: Magnetic Resonance Imaging in Löffler Endocarditis. Circ Rep 1(12): 628-629,
2019
13. Ohtsubo T, Shibata R, Kai H, Okamoto R, Kumagai E, Kawano H, Fujiwara A, Kitazono T, Murohara T, Arima H.
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial
infarction or heart failure: a systematic review and meta-analysis. Hypertens Res. 42(5):641-649, 2019 (IF:3.217) ＊14. Okamoto R, Kumagai E, Kai H, Shibata R, Ohtsubo T, Kawano H, Fujiwara A, Ito M, Fukumoto Y, Arima H. Effects oflowering diastolic blood pressure to <80 mmHg on cardiovascular mortality and events in patients with coronary artery disease:a systematic review and meta-analysis. Hypertens Res. 42(5):650-659, 2019 (IF:3.217) ＊15. Okamura G, Kawano H, Yoshida N, Koga S, Ikeda S, Ichinose K, Maemura K: Successful Treatment With Rivaroxaban for anAcute Pulmonary Thromboembolism in a Patient With Primary Antiphospholipid Antibody Syndrome. J Cardiol Cases 21(2):79-81, 201916. Okamura K, Nakagama Y, Takeda N, Soma K, Sato T, Isagawa T, Kido Y, Sakamoto M, Manabe I, Hirata Y, Komuro I, Ono
M: Therapeutic targeting of mitochondrial ROS ameliorates murine model of volume overload cardiomyopathy. J Pharmacol
Sci 141(1): 56-63, 2019 (IF:2.439) ＊17. Sato D, Ikeda S, Koga S, Yamagata Y, Eguchi M, Yonekura T, Tsuneto A, Yoshimuta T, Koide Y, Kawano H, Maemura K:
Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer
and/or older age. Heart Vessels. 34(4): 678-687, 2019 (IF:1.62) ＊1

18. Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T,Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K,Baba H, Matsui K, Tsujita K: Differential predictive factors for cardiovascular events in patients with or without cancer history.
Medicine (Baltimore) 98(44): e17602, 2019 (IF:1.87) ＊19. Tateishi Y, Kanamoto T, Nakaoka K, Yoshimura S, Miyazaki T, Shiraishi H, Morimoto S, Tsuneto A, Maemura K, Morofuji Y,Horie N, Izumo T, Tsujino A: A Score Using Left Ventricular Diastolic Dysfunction to Predict 90-day Mortality in Acute
Ischemic Stroke: The DONE Score. J Neurol Sci 398:157-162, 2019 (IF:2.651) ＊20. Tateishi Y, Kanamoto T, Yamashita K, Hirayama T, Yoshimura S, Miyazaki T, Tsuneto A, Maemura K, Morofuji Y, Horie N,Izumo T, Shiraishi H, Tsujino A: Biomarkers of Cardiac Dysfunction as Risk Factors in Cryptogenic Stroke. Cerebrovasc Dis48(3-6):132–139, 2019 (IF:1.646) ＊21. Tomiyama H, Ohkuma T, Ninomiya T, Nakano H, Matsumoto C, Avolio A, Kohro T, Higashi Y, Maruhashi T, Takase B,Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y,Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Chikamori T, Yamashina A: Brachial-Ankle Pulse Wave Velocity Versus Its
Stiffness Index β-Transformed Value as Risk Marker for Cardiovascular Disease. J Am Heart Assoc 8(24): e013004, 2019
(IF:4.66) ＊22. Wake M, Takeda N, Isagawa T, Sato T, Nakagama Y, Morioka MS, Hirota Y, Asagiri M, Maemura K, Manabe I, Tanabe K,Komuro I: Cell Cycle Perturbation Induces Collagen Production in Fibroblasts. Int Heart J 60(4): 958-963, 2019 (IF:2.226) ＊◇☆
23. Yoshimuta T, Tsuneto A, Okajima T, Tanaka H, Minami T, Yamagishi M, Ikeda S, Kawano H, Maemura K: Doppler
ultrasound diagnosis of transient leg malperfusion caused by dynamic obstruction in a patient with chronic aortic dissection.
Echocardiography 36(1): 189-191, 2019 (IF:1.287) ＊A-b
1. Ikeda S, Maemura K: Interaction Between the Gut-Kidney-Cardiovascular Systems Is Key in Predicting the Prognosis ofPatients with Cardiovascular Disease. Int Heart J 60(1): 7-9, 2019 (IF:2.226) ＊A-e
1. Chiba A, Kudo T, Ideguchi R, Altay M, Koga S, Yonekura T, Tsuneto A, Morikawa M, Ikeda S, Kawano H, Koide Y, UetaniM, Maemura K: Comparison of whether a beginner can be close to an expert with an artificial neural network in myocardial
perfusion imaging. Eur Heart J Cardiovasc Imaging 20(Suppl_3): iii108, 2019
2. Koga S, Ikeda S, Akashi R, Yamagata Y, Yonekura T, Kawano H, Maemura K: Serum soluble Klotho is associated with extentof coronary artery calcification in patients with stable angina pectoris undergoing percutaneous coronary intervention. EurHeart J 40(Suppl_1): 853, 2019
3. Koga S, Ikeda S, Akashi R, Yamagata Y, Yonekura T, Kawano H, Maemura K: Potential for drug-drug interaction betweenvonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease.
Eur Heart J 40(Suppl_1): 4006, 2019
4. Honda T, Koga S, Akashi R, Yamagata Y, Yonekura T, Ikeda S, Kawano H, Maemura K: Direct Comparison of Resting
Full-cycle Ratio With Fractional Flow Reserve in Physiological Assessment of Intermediate Coronary Artery Stenosis.
Circulation 140(Suppl_1): A12279, 2019
5. Koga S, Ikeda S, Akashi R, Yamagata Y, Yonekura T, Kawano H, Maemura K: Serum Soluble Klotho As A Novel Biomarker
For Coronary Artery Calcification Of Culprit Lesions In Patients With Stable Angina Pectoris. Circulation 140(Suppl_1):
A16567, 2019

B 邦文
B-a
1. 南 貴子，河野浩章，恒任 章，吉牟田剛，前村浩二：服薬管理能力の低下した高齢者に認められた左房内ボール状血栓．超音波医学 46（5）：467-468，2019
2. 川浪のぞみ，古島早苗，恒任 章， 南 貴子，木村由美子，海端亜季，井手愛子，西田祐輝，賀来敬仁，江石清行，前村浩二，柳原克紀：僧帽弁に非細菌性血栓性心内膜炎を認めた Trousseau 症候群の１例．超音波検査技術 44（2）：318，2019B-b
1. 古賀聖士，前村浩二：出血リスク軽減も月号）15（1)：17，2019

実臨床では患者に応じた対応が必要．世界の医学・医療を知る MMJ（22. 熊谷飛鳥，倉田里穂，尾崎惠一，砂河孝行，仙波宏章，武田憲彦，前村浩二，米澤 朋：ヒトγδT 細胞抗腫瘍活
性を用いた新規免疫細胞治療のための創薬研究．BIO Clinica 34（9）：959-963，2019

B-c2

1. 前村浩二：睡眠・サーカディアンリズムと心不全.（日本臨牀
究の進歩―,日本臨牀社, 東京，pp.579-586 所収）2019増刊号

心不全（第 2 版）下―最新の基礎・臨床研

2. 前村浩二：たこつぼ心筋障害 Takotsubo cardiomyopathy.（福井次矢，高木誠，小室一成（総編集）：今日の治療指針
2019，医学書院，東京，pp.428-429 所収）2019
3. 河野浩章，前村浩二：ＭＲＡの多施設共同試験を解説する (HFpEF): TOPCAT（伊藤 浩（編）：心臓を守る！ミネラルコルチコイド受容体拮抗薬 MRA の実力を Q&A で解き明かす，文光堂，大阪，pp. 79-80 所収）2019
4. 恒任 章，江石清行，前村浩二：弁膜症 器質性僧帽弁閉鎖不全．（別冊 日本臨牀の他の循環器疾患を含めて― I，日本臨牀社，東京，pp.375-380 所収）2019

循環器症候群（第 3 版）―そB-e
1. 黒部昌也，古賀聖士，恒任 章，池田聡司，河野浩章，前村浩二：重症冠動脈病変を合併した重症大動脈弁狭窄症に対し経皮的冠動脈形成術と経カテーテル大動脈弁留置術を一期的に施行した 1 例．日本老年医学会雑誌 56（4）：572，2019
2. 山方勇樹，池田聡司，米倉 剛，古賀聖士，河野浩章，前村浩二：慢性血栓塞栓性肺高血圧症における BPA の腎機能への影響．脈管学 59（Suppl.）： S218-S219，2019
3. 川浪のぞみ，古島早苗，恒任 章，南 貴子，木村由美子，海端亜季，井手愛子， ⻄田祐輝，賀来敬仁，江石清行，前村浩二，柳原克紀：僧帽弁に非細菌性血栓性心内膜炎を認めた Trousseau 症候群の 1 例．超音波検査技術 44（2）：318，2019
4. 魏 碩俣，砂河孝行，江口正倫，佐藤大輔，池田聡司，河野浩章，前村浩二：低酸素環境によるマクロファージ機能制御機構．血管 42（1）： 56，2019

論文研究業績集計表
論文数一覧
A-a2019
23A-b1

A-c0A-d0A-e
5

合計
29SCI
19B-a2B-b2

B-c4

学会発表数一覧
A-a2019

A-bｼﾝﾎﾟｼﾞｳﾑ

00A-b
学会
5合計

B-a53B-b学会
69

B-bｼﾝﾎﾟｼﾞｳﾑ

2合計

総計

74

79

論文総数に係る教員生産係数一覧

2019

欧文論文総数
論文総数

教員生産係数（欧文論文）SCI 掲載論文数
欧文論文総数

教員生産係数（SCI 掲載論文）

0.707

2.2310.655

1.462

Impact factor 値一覧
Impact factor
201961.176

教員当たり Impact factor
4.706

論文当たり Impact factor
3.220

3B-d
0B-e
4

合計
12総計41